When the COVID-19 vaccines started to be approved late last year—and even before—Roanica Paisley wasted no time in gauging how workers at her organization felt about the vaccines on the horizon. She had several conversations with workers and listened to their fears: The vaccines were developed quickly. They were approved too fast. Did they have enough testing? Enough data? Were they safe?
Paisley, director of human resources at Rising Ground, a large New York City human services nonprofit, asked because she immediately had a lofty goal in mind: to convince all of the nonprofit’s 1,600 workers to get